NCT05483387View on ClinicalTrials.gov

Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments.

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Intraarticular FractureExtraarticular FracturePseudarthrosisArthrosis

Interventions

DEVICE

Treatment with HBS 2 Resorb Mg

Treatment of fractures, arthrodesis or pseudarthroses of small bones and bone fragments

Trial Locations (1)

13353

RECRUITING

Centrum für Muskuloskeletale Chirurgie (CMSC), Berlin

All Listed Sponsors

collaborator

Clinical Study Centers, LLC

OTHER

lead

KLS Martin

INDUSTRY

NCT05483387 - Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments. | Biotech Hunter | Biotech Hunter